Top 10 selling drugs in 2013
1
|
Abilify
|
aripiprazole
|
Otsuka
|
$6,460,215,394
|
2
|
Nexium
|
esomeprazole
|
AstraZeneca
|
$6,135,667,614
|
3
|
Humira
|
adalimumab
|
AbbVie
|
$5,549,996,855
|
4
|
Crestor
|
rosuvastatin
|
AstraZeneca
|
$5,310,818,889
|
5
|
Cymbalta
|
duloxetine
|
Eli
Lilly
|
$5,219,860,418
|
6
|
Advair Diskus
|
fluticasone
propionate/salmeterol
|
GlaxoSmithKline
|
$5,121,312,668
|
7
|
Enbrel
|
etanercept
|
Amgen
|
$4,681,201,645
|
8
|
Remicade
|
infliximab
|
Centocor
|
$4,098,233,242
|
9
|
Copaxone
|
glatiramer
acetate
|
Teva
Pharm
|
$3,697,182,238
|
10
|
Neulasta
|
pegfilgrastim
|
Amgen
|
$3,580,364,758
|
Comments